Federal guidelines will speed bench-to-bedside research and advance clinical trials using gene editing technology

March 3, 2020

As laboratory breakthroughs using CRISPR gene editing technology advance from bench to bedside – including a lung cancer clinical trial from the Gene Editing Institute at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute – federal policies and guidelines to ensure safe, effective therapies have lagged behind. But last month they took a major […] Read more